FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, specifically pharmaceutics. A cytokine-containing composition for treating viral diseases contains (wt %): alpha-fetoprotein - 0.001-99, cytokine preparation - the rest. As cytokine, the following preparations may be used - interferon-2-alpha, interleukin-1-beta, receptor interleukin agonist.
EFFECT: use of the declared composition provides higher clinical effectiveness in the diseases caused by human viral diseases (hepatitis B virus and various genotypes of hepatitis C virus, rubella virus, Epstein-Barr virus, combined hepatitis C and human immunodeficiency viruses).
10 ex, 3 tbl, 7 dwg
Title | Year | Author | Number |
---|---|---|---|
MEDICATION COMPOSITION AND METHOD OF ITS OBTAINING FOR TREATMENT OF CHRONIC VIRAL HEPATITIS B OR C AND AIDS | 2010 |
|
RU2440133C2 |
METHOD OF CHRONIC VIRUS HEPATITIS TREATMENT | 2008 |
|
RU2369403C1 |
COMPOSITION BASED ON INTERFERON I OR III TYPE AND GAMMA-D-GLUTAMINYL-L-TRYPTOPHAN FOR PREVENTION AND TREATMENT OF INFECTIOUS DISEASES AND IMMUNODEFICIENCY CONDITIONS (OPTIONS) | 2014 |
|
RU2672861C2 |
ZINC-CONTAINING AEROSOL COMPOSITION | 2009 |
|
RU2410082C1 |
INTERLEUKIN COMPOSITION (VERSIONS) | 2009 |
|
RU2432170C2 |
METHOD FOR TREATING INFECTIOUS DISEASES AND COMPLEX MEDICATION FOR TREATMENT OF INFECTIOUS DISEASES | 2011 |
|
RU2577299C2 |
METHOD OF TREATING CHRONIC VIRAL HEPATITIS C | 2010 |
|
RU2429877C1 |
METHOD OF IMMUNOTHERAPY OF PURULENT RHINOSINUSITIS | 2010 |
|
RU2457789C2 |
METHOD FOR PREPARING RECOMBINANT INTERFERON ALPHA-2b AND INTERFERON-CONTAINING PREPARATION (VARIANTS) | 2005 |
|
RU2294372C1 |
METHOD FOR PREDICTION OF FORMATION OF VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C | 2011 |
|
RU2461834C1 |
Authors
Dates
2012-04-20—Published
2009-03-26—Filed